Surya Pharmaceutical revises FCCB issue conversion terms

Surya Pharmaceutical Ltd has announced that the Board of Directors of the Company at its meeting held on October 28, 2006, inter alia, has revised the convertibility of Foreign Currency Convertible Bonds issued by the Company, in terms of Reset Clause 7.2.4 of the Trust Deed Agreement, whereby effective October 28, 2006 onwards, the Company shall allot 313.1324 fully paid Equity shares for each FCCB of USD 1000.00. The Authorised Capital of the Company is sufficient to accommodate the marginal increase in Equity Shares to be issued upon conversion.

Source : Equity Bulls

Keywords